EP3886991
KRas G12C hindrar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
4.12.2020EP published:
21.9.2022EP application number:
20834024.0
EP translation filed:
17.10.2022Grant published:
15.11.2022EPO information:
European Patent Register
Max expiry date:
3.12.2040Expiry date:
3.12.2026Next due date:
31.12.2026
Title in English:
KRAS G12C INHIBITORSLanguage of the patent:
English
Timeline
Today
4.12.2020EP application
21.9.2022EP Publication
17.10.2022Translation submitted
15.11.2022Registration published
3.12.2026Expires
Owner
Name:
Eli Lilly and CompanyAddress:
Lilly Corporate Center, Indianapolis, IN 46285, US
Inventor
Name:
BOULET, Serge LouisAddress:
Indianapolis, Indiana 46206-6288, US
Name:
FORTNER, Kevin CharlesAddress:
Indianapolis, Indiana 46206-6288, US
Name:
GUO, DeqiAddress:
Indianapolis, Indiana 46206-6288, US
Name:
HYMAN, David MichaelAddress:
Indianapolis, Indiana 46206-6288, US
Name:
PENG, Sheng-BinAddress:
Indianapolis, Indiana 46206-6288, US
Name:
SI, ChongAddress:
Indianapolis, Indiana 46206-6288, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201962946586 PDate:
11.12.2019Country:
US
Classification
Categories:
A61P 35/00, C07D 487/04, C07D 498/04, A61K 31/553
Annual fees
Number
Paid
Expires
Payer
Number: 3
Paid: 22.11.2022
Expires: 3.12.2023
Payer: Árnason Faktor ehf.
Number: 4
Paid: 29.11.2023
Expires: 3.12.2024
Payer: Árnason Faktor ehf.
Number: 5
Paid: 21.11.2024
Expires: 3.12.2025
Payer: Árnason Faktor ehf.
Number: 6
Paid: 5.12.2025
Expires: 3.12.2026
Payer: Árnason Faktor ehf.